Global Endoscope Reprocessing Market is estimated to be US$ 4.58 billion by 2030 with a CAGR of 8.90

Author: Siju Thomas

Global Endoscope Reprocessing Market accounted for US$ 1.96 billion in 2020 and is estimated to be US$ 4.58 billion by 2030 and is anticipated to register a CAGR of 8.90%. Endoscope reprocessing is benefiting from the growing disinfection technology industry. Due to a focus on high cleanliness standards and rising pressures for sterilised and disinfected medical devices in hospitals and clinics, the endoscope reprocessing business is booming. Endoscopes are used to detect, diagnose, and treat a variety of gastrointestinal problems. However, because of their composite nature and varied use in medical operations, the risk of infection transmission associated with endoscopes is typically significant. As a result, many countries' health agencies have implemented strict endoscope reprocessing regulations in order to improve security and reduce the spread of infections. These standards ensure that endoscopes go through a series of specific cleaning and disinfection protocols before being utilised on any patient. AER is also being introduced by a number of manufacturers for precise, consistent, and cost-effective operation. Microorganisms on reused endoscopes are killed by exposing their interior channels and outside surfaces to high-level purifier or liquid chemical sterilant solutions in automated endoscope reprocessors.

The report " Global Endoscope Reprocessing Market, by Product (HLD and Test Strips, Detergents & Wipes, AER (Portable, Standalone), Endoscope Tracking Solutions, Endoscope Drying, Storage, & Transport Systems), By End User (Hospitals, ASCs & Clinics) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

  • In 2021, Getinge partnered with researchers from the School of Business, Economics and Law at the University of Gothenburg, Sweden, on customer-centric innovation and sustainability. This will help the company gain access to the researchers’ socially relevant and applicable knowledge.
  • In 2020, STERIS entered into a definitive agreement to acquire Cantel through a US subsidiary. The acquisition will enable STERIS to offer a broader set of Customers a more diversified selection of infection prevention and procedural products and services.
  • In 2020, Olympus Corporation launched OER-Elite.

Analyst View:

Endoscope-related infections caused by infected endoscopes are still being reported over the world. Although endoscope-associated infections are most commonly connected with duodenoscopes, recent reports have also mentioned epidemics involving gastroscopes, colonoscopes, and bronchoscopes. Despite proper steps to conduct endoscope reprocessing, the number of infections caused by endoscope use has been relatively high. Duodenoscope contamination rates have been reported to range from 0.3 percent to 30 percent in recent research, while linear echoendoscopes with a comparable complex construction, gastroscopes, and colonoscopes can also be contaminated. Due to their persistence in biofilms, Klebsiella pneumoniae and Pseudomonas aeruginosa are frequently involved in endoscopy-related epidemics. Damaged elements, such as biopsy channels, are susceptible to biofilm formation due to high wear and strain. Such infections, which are caused by incorrect sterilisation, are forcing healthcare stakeholders to adopt a number of steps to limit the risk of infection for patients.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Endoscope-Reprocessing-Market-4820

Key Market Insights from the report:

Global Endoscope Reprocessing Market accounted for US$ 1.96 billion in 2020 and is estimated to be US$ 4.58 billion by 2030 and is anticipated to register a CAGR of 8.90%. The Global Endoscope Reprocessing Market is segmented based on Product, End-User and region.

  • Based on Product, Global Endoscope Reprocessing Market is segmented into HLD and Test Strips, Detergents & Wipes, AER (Portable, Standalone), Endoscope Tracking Solutions, Endoscope Drying, Storage, & Transport Systems.
  • Based on End-User, Global Endoscope Reprocessing Market is segmented into Hospitals, ASCs & Clinics.
  • By Region, the Global Endoscope Reprocessing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Endoscope Reprocessing Market:

The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.